Utility of PET scans to predict disease relapse in pediatric patients with Hodgkin lymphoma
Authors:
- 21 February 2007
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 48 (4) , 399-402
Abstract
Background Positron emission tomography (PET) differentiates normal from abnormal cells based on metabolic activity. Numerous studies report that PET scan offers increased sensitivity, specificity and predictive values as compared to computed tomography (CT) in adult lymphoma patients. Procedure Twenty‐three consecutive pediatric Hodgkin lymphoma (HL) patients were evaluated with PET scan either at diagnosis or during treatment, then at therapy completion and in follow‐up. Results Twenty two of the 23 patients had a negative PET scan at the end of therapy; however, ten later developed a positive scan for a total of 11 (47.8%) patients with a positive post treatment PET scan. Six tissue biopsies were performed in five patients; four specimens were negative for disease and two confirmed HL relapse. Six patients were monitored clinically and remained asymptomatic; four had resolution of abnormalities on repeat PET while two had persistently positive, but stable PET scan findings and continue to be in remission at 11 and 40 months following treatment. Twelve (52.2%) patients of the original cohort have had consistently negative PET scans and have not relapsed. Conclusions PET is a sensitive (100%), but not a specific (57.1%) method for evaluating post‐treatment pediatric HL patients with a strong negative predictive value (NPV; 100%), but poor positive predictive value (PPV; 18.2%). We do not recommend treatment decisions be based solely on PET scan results. Pediatr Blood CancerKeywords
This publication has 11 references indexed in Scilit:
- Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?Annals of Oncology, 2005
- 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin?sPediatric Radiology, 2004
- Mediastinal Bulky Tumour in Hodgkin’s Disease and Prognostic Value of Positron Emission Tomography in the Evaluation of Post-Treatment Residual MassesActa Haematologica, 2004
- PET imaging in pediatric Hodgkin?s lymphomaPediatric Radiology, 2004
- FDG PET in the follow-up management of patients with newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s diseaseAnnals of Oncology, 2003
- [18F]FDG in childhood lymphoma: clinical utility and impact on managementEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin’s lymphomaAnnals of Oncology, 2001
- Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears?European Journal of Nuclear Medicine and Molecular Imaging, 2000
- Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan ImagingBlood, 1999